[Therapeutic results obtained with aminoglutethimide in advanced-stage breast cancer. Factors predictive of a response].
Paridaens
R J
RJ
Arrigo
C
C
Heuson
J C
JC
D000328:Adult; D000368:Aged; D000616:Aminoglutethimide / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000032:analysis / Q000188:drug therapy*; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis
D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D000616:Aminoglutethimide; D006854:Hydrocortisone
Résultats thérapeutiques obtenus avec l'aminoglutéthimide dans le cancer le cancer du sein au stade avancé. Facteurs predictifs de la réponse.